Cambridgeshire, United Kingdom

Angela Glen

This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Glen. Retrieved from https://idiyas.com/inventor/angela-glen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Cambridge, GB (2015 - 2016)
  • Cambridgeshire, GB (2017 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Angela Glen in Pharmaceutical Chemistry

Introduction

Angela Glen is a prominent inventor based in Cambridgeshire, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target orexin receptors. With a total of five patents to her name, her work has the potential to impact therapeutic approaches for various conditions.

Latest Patents

Among her latest patents, Angela has developed 1,2-substituted cyclopentanes as orexin receptor antagonists. The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein L, X, R, R, R, R, and R are defined in the specification. This invention also includes processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.

Career Highlights

Angela Glen is currently associated with Takeda Pharmaceutical Company Limited, where she continues to innovate and contribute to the field. Her expertise in pharmaceutical chemistry has positioned her as a valuable asset within the company.

Collaborations

Angela has collaborated with notable colleagues, including Charlotte Fieldhouse and Tatsuhiko Fujimoto. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Angela Glen's work exemplifies the innovative spirit of modern pharmaceutical research. Her contributions to the development of orexin receptor antagonists highlight her commitment to advancing therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…